OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
002377 Hubei Guochuang Hi-Tech Material
- 2.71
- +0.02+0.74%
Not Open Apr 1 15:00 CST
2.48BMarket Cap-24.86P/E (TTM)
2.76High2.70Low101.35KlotVolume2.70Open2.69Pre Close27.67MTurnover1.12%Turnover RatioLossP/E (Static)916.33MShares3.9952wk High5.16P/B2.46BFloat Cap1.6552wk Low2.96Limit Up906.71MShs Float16.81Historical High2.42Limit Down2.23%Amplitude1.31Historical Low--Dividend TTM2.73Avg Price50.55KlotAsk--Div YieldTTM100Lot Size49.23KlotBid
Hubei Guochuang Hi-Tech Material Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -40.10%432.19M | -59.31%203.44M | -64.43%80.82M | -62.54%824.42M | -56.29%721.57M | -48.58%500.01M | -43.91%227.22M | -42.05%2.2B | -47.15%1.65B | -55.46%972.48M |
| Operating revenue | -40.10%432.19M | -59.31%203.44M | -64.43%80.82M | -62.54%824.42M | -56.29%721.57M | -48.58%500.01M | -43.91%227.22M | -42.05%2.2B | -47.15%1.65B | -55.46%972.48M |
| Other operating revenue | ---- | -76.13%2.85M | ---- | -10.68%17.4M | ---- | 426.55%11.93M | ---- | 222.81%19.48M | ---- | -17.01%2.27M |
| Total operating cost | -42.04%462.55M | -58.26%238.56M | -63.01%95.67M | -63.92%914M | -57.72%798.05M | -50.29%571.52M | -49.98%258.68M | -41.96%2.53B | -44.81%1.89B | -49.90%1.15B |
| Operating cost | -43.07%398.38M | -60.25%198.59M | -63.10%78.6M | -65.35%764.23M | -57.62%699.82M | -48.96%499.63M | -50.24%213M | -42.62%2.21B | -45.94%1.65B | -52.36%978.94M |
| Operating tax surcharges | -34.55%949.69K | -35.37%744.96K | 27.48%654.45K | -70.93%2.85M | -69.83%1.45M | -74.38%1.15M | -82.18%513.37K | -20.37%9.8M | -30.47%4.81M | -7.06%4.5M |
| Operating expense | 28.50%7.12M | 22.49%4.48M | -51.58%915.86K | -12.50%10.96M | -25.35%5.54M | -18.45%3.66M | 13.44%1.89M | 24.22%12.53M | -27.69%7.43M | -14.04%4.49M |
| Administration expense | -57.79%25.26M | -67.32%16.67M | -74.84%6.92M | -63.31%66.65M | -57.46%59.85M | -53.59%50.99M | -47.63%27.5M | -42.33%181.66M | -33.68%140.68M | -28.20%109.86M |
| Financial expense | 8.39%11.53M | 26.78%7.84M | -12.19%4.28M | -68.62%13.44M | -59.73%10.63M | -70.59%6.18M | -57.09%4.87M | -43.01%42.83M | -45.76%26.41M | -30.57%21.03M |
| -Interest expense (Financial expense) | -16.93%12.07M | -29.71%8.1M | -30.25%4.2M | -62.13%16.71M | -52.30%14.53M | -52.10%11.52M | -56.78%6.03M | -45.88%44.11M | -40.55%30.47M | -25.18%24.05M |
| -Interest Income (Financial expense) | 84.71%-1.15M | 86.77%-809.37K | 90.41%-143.48K | -23.76%-4.38M | -42.27%-7.53M | -71.06%-6.12M | -789.24%-1.5M | 68.30%-3.54M | 15.25%-5.29M | 16.76%-3.58M |
| Research and development | -6.91%19.32M | 3.44%10.25M | -60.49%4.31M | -30.65%55.87M | -63.55%20.75M | -67.90%9.91M | -47.28%10.91M | -25.49%80.56M | -34.93%56.93M | -33.74%30.86M |
| Credit Impairment Loss | -0.58%-19.08M | 178.87%22.5M | 30.65%9.26M | 42.58%-24.74M | 21.61%-18.97M | 471.55%8.07M | 618.78%7.09M | 57.57%-43.08M | -29.55%-24.2M | -62.08%1.41M |
| Asset Impairment Loss | ---- | ---- | ---- | 26.45%-34.73M | ---- | ---- | ---- | 88.31%-47.23M | ---- | ---- |
| Other net revenue | -52.05%-21.1M | 71.19%21.84M | 12.58%8.82M | 49.98%-59.3M | 27.23%-13.88M | 310.99%12.76M | 364.21%7.84M | 77.49%-118.53M | 93.97%-19.07M | -82.75%3.1M |
| Fair value change income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -97.79%10.66K | ---- | ---- |
| Invest income | -574.17%-3.01M | -218.85%-1.04M | -416.03%-455.67K | 54.79%-5.24M | 80.10%-446.13K | 56.80%-326.68K | 94.24%-88.3K | 64.07%-11.6M | -1,164.91%-2.24M | -229.52%-756.2K |
| -Including: Investment income associates | -96.91%-2.61M | 13.53%-766.26K | 23.11%-378.55K | 83.68%-2.1M | 57.65%-1.33M | 44.36%-886.19K | 71.87%-492.3K | 63.56%-12.89M | -74.62%-3.13M | -158.52%-1.59M |
| Asset deal income | -100.29%-6.64K | -100.29%-6.64K | ---- | 107.05%2.26M | 156.32%2.26M | 156.32%2.26M | ---- | -69.78%-32.08M | -1,105.33%-4.01M | -1,149.27%-4.01M |
| Other revenue | -69.62%996.73K | -86.21%379.29K | -97.39%21.91K | -79.53%3.16M | -71.20%3.28M | -57.43%2.75M | -62.41%840.04K | -48.16%15.44M | -46.70%11.39M | -53.86%6.46M |
| Operating profit | 43.04%-51.47M | 77.38%-13.29M | 74.47%-6.03M | 66.99%-148.87M | 64.70%-90.36M | 66.25%-58.76M | 78.59%-23.62M | 58.77%-451.01M | 58.27%-256M | -86.65%-174.08M |
| Add:Non operating Income | -99.30%16.02K | -99.24%16.02K | -97.36%38.14K | -24.77%2.65M | -6.37%2.29M | 16.35%2.12M | 29.47%1.45M | -17.60%3.53M | -36.02%2.44M | -22.65%1.82M |
| Less:Non operating expense | -95.98%239.36K | -96.64%199.96K | -99.67%41.1K | -84.53%7.31M | -75.94%5.95M | 285.13%5.95M | 637.39%12.52M | 90.15%47.26M | 223.33%24.73M | -70.80%1.55M |
| Total profit | 45.02%-51.69M | 78.47%-13.48M | 82.61%-6.03M | 68.97%-153.53M | 66.21%-94.02M | 63.99%-62.6M | 68.71%-34.7M | 55.60%-494.75M | 54.92%-278.29M | -80.67%-173.81M |
| Less:Income tax cost | 20.21%-1.85M | -119.72%-107.95K | -115.88%-173.94K | -122.74%-5.5M | -68.58%-2.32M | 68.17%547.31K | 184.04%1.1M | 34.03%24.2M | 45.23%-1.38M | 166.94%325.44K |
| Net profit | 45.65%-49.84M | 78.83%-13.37M | 83.63%-5.86M | 71.48%-148.03M | 66.88%-91.7M | 63.74%-63.14M | 67.34%-35.79M | 54.17%-518.95M | 54.96%-276.91M | -81.93%-174.13M |
| Net profit from continuing operation | -41.03%-49.84M | -97.22%-13.37M | -6,539.91%-5.86M | -1,558.01%-93.26M | 87.24%-35.34M | 96.11%-6.78M | 99.92%-88.26K | 100.56%6.4M | 54.96%-276.91M | -81.93%-174.13M |
| Net income from discontinuing operating | ---- | ---- | ---- | 89.58%-54.76M | ---56.36M | ---56.36M | ---35.71M | ---525.35M | ---- | ---- |
| Less:Minority Profit | -343.51%-3.66M | -93.27%88.04K | -100.00%0.94 | -104.13%-880.62K | 323.29%1.5M | 174.21%1.31M | 177.50%1.12M | 305.36%21.33M | 91.17%-673.96K | 55.00%-1.76M |
| Net profit of parent company owners | 50.46%-46.18M | 79.12%-13.46M | 84.12%-5.86M | 72.76%-147.15M | 66.26%-93.21M | 62.61%-64.45M | 65.87%-36.91M | 51.85%-540.28M | 54.51%-276.24M | -87.77%-172.37M |
| Earning per share | ||||||||||
| Basic earning per share | 50.44%-0.0504 | 79.09%-0.0147 | 84.12%-0.0064 | 72.88%-0.16 | 66.27%-0.1017 | 62.63%-0.0703 | 65.85%-0.0403 | 51.64%-0.59 | 54.50%-0.3015 | -87.72%-0.1881 |
| Diluted earning per share | 50.44%-0.0504 | 79.09%-0.0147 | 84.12%-0.0064 | 72.88%-0.16 | 66.27%-0.1017 | 62.63%-0.0703 | 65.85%-0.0403 | 51.64%-0.59 | 54.50%-0.3015 | -87.72%-0.1881 |
| Other composite income | -70K | -70K | 5.88%-160K | -190.91%-170K | ||||||
| Other composite income of parent company owners | ---70K | ---70K | ---- | 5.88%-160K | ---- | ---- | ---- | -190.91%-170K | ---- | ---- |
| Total composite income | 45.57%-49.91M | 78.72%-13.44M | 83.63%-5.86M | 71.45%-148.19M | 66.88%-91.7M | 63.74%-63.14M | 67.34%-35.79M | 54.15%-519.12M | 54.96%-276.91M | -81.93%-174.13M |
| Total composite income of parent company owners | 50.38%-46.25M | 79.01%-13.53M | 84.12%-5.86M | 72.74%-147.31M | 66.26%-93.21M | 62.61%-64.45M | 65.87%-36.91M | 51.83%-540.45M | 54.51%-276.24M | -87.77%-172.37M |
| Total composite income of minority owners | -343.51%-3.66M | -93.27%88.04K | -100.00%0.94 | -104.13%-880.62K | 323.29%1.5M | 174.21%1.31M | 177.50%1.12M | 305.36%21.33M | 91.17%-673.96K | 55.00%-1.76M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.